The original version of this article unfortunately contained a mistake. Due to a typesetting error ‘sorafenib pretreated’ was changed to ‘sorafenibpretreated’ throughout the article. The correct spelling is ‘sorafenib pretreated. There were also minor errors in Fig. 1 and Fig. 3. The original article has been corrected

Correction: Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression (British Journal of Cancer, (2021), 10.1038/s41416-021-01334-9) / Decaens, T.; Barone, C.; Assenat, E.; Wermke, M.; Fasolo, A.; Merle, P.; Blanc, J. -F.; Grando, V.; Iacobellis, A.; Villa, E.; Trojan, J.; Straub, J.; Bruns, R.; Berghoff, K.; Scheele, J.; Raymond, E.; Faivre, S.. - In: BRITISH JOURNAL OF CANCER. - ISSN 0007-0920. - (2021), pp. N/A-N/A. [10.1038/s41416-021-01403-z]

Correction: Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression (British Journal of Cancer, (2021), 10.1038/s41416-021-01334-9)

Villa E.;
2021

Abstract

The original version of this article unfortunately contained a mistake. Due to a typesetting error ‘sorafenib pretreated’ was changed to ‘sorafenibpretreated’ throughout the article. The correct spelling is ‘sorafenib pretreated. There were also minor errors in Fig. 1 and Fig. 3. The original article has been corrected
2021
N/A
N/A
Correction: Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression (British Journal of Cancer, (2021), 10.1038/s41416-021-01334-9) / Decaens, T.; Barone, C.; Assenat, E.; Wermke, M.; Fasolo, A.; Merle, P.; Blanc, J. -F.; Grando, V.; Iacobellis, A.; Villa, E.; Trojan, J.; Straub, J.; Bruns, R.; Berghoff, K.; Scheele, J.; Raymond, E.; Faivre, S.. - In: BRITISH JOURNAL OF CANCER. - ISSN 0007-0920. - (2021), pp. N/A-N/A. [10.1038/s41416-021-01403-z]
Decaens, T.; Barone, C.; Assenat, E.; Wermke, M.; Fasolo, A.; Merle, P.; Blanc, J. -F.; Grando, V.; Iacobellis, A.; Villa, E.; Trojan, J.; Straub, J.; Bruns, R.; Berghoff, K.; Scheele, J.; Raymond, E.; Faivre, S.
File in questo prodotto:
File Dimensione Formato  
s41416-021-01403-z.pdf

Open access

Tipologia: Versione pubblicata dall'editore
Dimensione 222.37 kB
Formato Adobe PDF
222.37 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1249605
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 1
social impact